MUDr. Michal Dufek, Ph.D.
Office for Specialised Education of Doctors and Non-Medical Health Professionals
E‑mail: |
---|
Total number of publications: 36
2024
-
Case report: Susac syndrome-two ends of the spectrum, single center case reports and review of the literature
Frontiers in Neurology, year: 2024, volume: 15, edition: February 2024, DOI
-
Průběh onemocnění asociovaného s tvorbou protilátek proti myelinovému oligodendrocytárnímu glykoproteinu (MOGAD) - soubor pacientů
Ceska a slovenska neurologie a neurochirurgie, year: 2024, volume: 87, edition: 2, DOI
-
Real-world effectiveness of cladribine as an escalation strategy for MS: Insights from the Czech nationwide ReMuS registry
JOURNAL OF CENTRAL NERVOUS SYSTEM DISEASE, year: 2024, volume: 16, edition: June 2024, DOI
-
The Czech National MS Registry (ReMuS): Data trends in multiple sclerosis patients whose first disease-modifying therapies were initiated from 2013 to 2021
Biomedical Papers, Olomouc: Palacky University, year: 2024, volume: 168, edition: 3, DOI
2023
-
Does initial high efficacy therapy in multiple sclerosis surpass escalation treatment strategy? A comparison of patients with relapsing-remitting multiple sclerosis in the Czech and Swedish national multiple sclerosis registries
MULTIPLE SCLEROSIS AND RELATED DISORDERS, year: 2023, volume: 76, edition: August 2023, DOI
-
MOGAD s fenotypem akutní myelitídy v dětském věku.
Year: 2023, type: Appeared in Conference without Proceedings
2021
-
Alterations in Sensorimotor and Mesiotemporal Cortices and Diffuse White Matter Changes in Primary Progressive Multiple Sclerosis Detected by Adiabatic Relaxometry
Frontiers in Neuroscience, year: 2021, volume: 15, edition: September 2021, DOI
-
Léčba roztroušené sklerózy perorálním kladribinem
Neurologie pro praxi, year: 2021, volume: 22, edition: (3), DOI
-
Perorální kladribin v léčbě roztroušené sklerózy - data z celostátního registru ReMuS®
CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, year: 2021, volume: 84, edition: 6, DOI
2020
-
Terapie encefalomyelitidy asociované s anti-MOG protilátkami z různých úhlů pohledu.
Year: 2020, type: Appeared in Conference without Proceedings